Ethylestrenol
Maxibolin (ethylestrenol) is a small molecule pharmaceutical. Ethylestrenol was first approved as Maxibolin on 1982-01-01. It is used to treat anemia and osteoporosis in the USA. The pharmaceutical is active against androgen receptor.
Download report
Favorite
Commercial
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
Labels
FDA
EMA
No data
Indications
FDA
EMA
Indication | Ontology | MeSH | ICD-10 |
---|---|---|---|
anemia | EFO_0004272 | D000740 | D64.9 |
osteoporosis | EFO_0003882 | D010024 | M81.0 |
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
HCPCS
No data
Clinical
Indications Phases 4
No data
Indications Phases 3
No data
Indications Phases 2
No data
Indications Phases 1
No data
Indications Without Phase
No data
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common name | ETHYLESTRENOL |
INN | ethylestrenol |
Description | Ethylestrenol is a 17beta-hydroxy steroid that is estrane containing a double bond between positions 4 and 5 and substituted by an ethyl group and a hydroxy group at the 17alpha and 17beta positions, respectively. It is an anabolic steroid that has little androgenic effect and only slight progestational activity. It has been used to promote growth in boys with delayed bone growth. It has a role as an anabolic agent. It is a tertiary alcohol and a 17beta-hydroxy steroid. |
Classification | Small molecule |
Drug class | estrogens |
Image (chem structure or protein) | |
Structure (InChI/SMILES or Protein Sequence) | CC[C@]1(O)CC[C@H]2[C@@H]3CCC4=CCCC[C@@H]4[C@H]3CC[C@@]21C |
Identifiers
PDB | — |
CAS-ID | 965-90-2 |
RxCUI | 4162 |
ChEMBL ID | CHEMBL1200623 |
ChEBI ID | 31578 |
PubChem CID | 13765 |
DrugBank | DB01493 |
UNII ID | ADC79EK5Q8 (ChemIDplus, GSRS) |
Target
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Subscribe for the real data
Additional graphs summarizing 60 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
Subscribe for the real data
6 adverse events reported
View more details
Premium feature
Learn more about premium features at pharmakb.com
Learn more